tweetindex
RU

CancerNetwork® ✓

@CancerNetwrk · Cranbury, NJ · joined 27 Feb 2009

Home of the journal ONCOLOGY®, CancerNetwork® offers different perspectives on oncology/hematology through review articles, news, podcasts, blogs, and more.

30 129Followers
772Following
23 536Posts total
3.8KViews on collected posts

Последние посты

🚨 FDA approves Lutetium Lu 177 dotatate injection for patients with somatostatin receptor-positive GEP-NETs. #NETs #gicsm #radonc | @FDADrugs https://t.co/HaEvHZjIVm https://t.co/tGULRhjZMX
786 views · 2 likes · 1 reposts · 0 replies Open on X →
Daraxonrasib elicited activity in patients with previously treated advanced RAS-mutant NSCLC. 💠 31% ORR at 120 mg or less 💠 34% ORR at 160 mg to 220 mg 💠 37% ORR at 300 mg https://t.co/qajig9dkdW #lcsm #NSCLC #oncology #cancer 538 views · 1 likes · 0 reposts · 0 replies Open on X →
Data from the phase 3 DeLLphi-305 trial revealed that durvalumab/tarlatamab significantly improved overall survival as 1L maintenance in ES-SCLC. https://t.co/G4w7undN8T #lcsm #SCLC #oncology #cancer 527 views · 0 likes · 0 reposts · 0 replies Open on X →
The @FDA has approved aminolevulinic acid hydrochloride (Ameluz), a 10% topical gel, in combination with photodynamic therapy for patients with superficial basal cell carcinoma. This approval marks the first and only photodynamic therapy for the treatment of a skin cancer. Read
385 views · 2 likes · 0 reposts · 0 replies Open on X →
"Crown remains the crown." A thoracic oncologist ranks 5 lung cancer trials blind — and one keeps beating the rest. https://t.co/ixe9VV8ui1 #LungCancer #Oncology https://t.co/n50QCYO7tH
1.6K views · 2 likes · 3 reposts · 0 replies Open on X →

На фоне аккаунтов своего размера

5 постов за последние 90 дней рядом с диапазоном 10K–100K подписчиков. ниже своих по обоим показателям — и по охвату, и по отклику.

Медианные просмотры538этот аккаунт924медиана для 10K–100K
Охват, %1.79%этот аккаунт3.62%медиана для 10K–100K
Вовлечённость, %0.38%этот аккаунт1.52%медиана для 10K–100K
ПоказательЭтот аккаунтМедиана для 10K–100KОтношение
Медианные просмотры на пост5389240.58×
Охват (просмотры ÷ подписчики)1.79%3.62%0.49×
Вовлечённость0.38%1.52%0.25×

Другие в этом диапазоне →   Сравнить с другим аккаунтом →   Как считаются эти ориентиры →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

1.6K11 Sep
38514 Sep
527
538
78615 Sep

Last 5 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.45%11 Sep
0.52%14 Sep
0.00%
0.19%
0.38%15 Sep

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.52%.

What the audience does

Likes38.9%7 in total
Reposts22.2%4 in total
Quotes11.1%2 in total
Bookmarks27.8%5 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Похожие аккаунты